Concepedia

Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial

Aurelio Maggio, Antonis Kattamis, Mariagrazia Felisi, Giorgio Reggiardo, Amal El‐Beshlawy, Mohamed Béjaoui, Laila M. Sherief, Soteroula Christou, Carlo Cosmi, Oscar Della Pasqua,

The Lancet Haematology · 2020 · 72 citations · 12 references

DOI

Concepts

References

12

Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance

Timothy G. St. Pierre, Paul R. Clark, Wanida Chua‐anusorn et al. · Blood · 2004 · 901 citations

, , +15

Survey of unlicensed and off label drug use in paediatric wards in European countries

Sharon Conroy · BMJ · 2000 · 741 citations · Full text

, , +5

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia

Maria Domenica Cappellini · Blood · 2005 · 719 citations · Full text

, , +13

Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis

Dudley J. Pennell · Blood · 2005 · 486 citations

, , +15

Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT)

Maria Domenica Cappellini, Alan R. Cohen, John B. Porter et al. · 2014 · 403 citations

, , +10